| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/AJE/KWS197 |
| P698 | PubMed publication ID | 22582207 |
| P50 | author | Richard Platt | Q91067808 |
| Grace M Lee | Q105289067 | ||
| Tracy A Lieu | Q105724609 | ||
| Martin Kulldorff | Q43862528 | ||
| Daniel A Salmon | Q57294972 | ||
| P2093 | author name string | Cheryl N McMahill-Walraven | |
| Melisa Rett | |||
| Peter M Wahl | |||
| Robert Ball | |||
| W Katherine Yih | |||
| P2860 | cites work | The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review | Q37352531 |
| Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. | Q38438386 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pandemic | Q12184 |
| immunization safety | Q105259234 | ||
| immunization | Q1415366 | ||
| P304 | page(s) | 1120-1128 | |
| P577 | publication date | 2012-05-11 | |
| P1433 | published in | American Journal of Epidemiology | Q4744243 |
| P1476 | title | Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010. | |
| P478 | volume | 175 |
| Q38172268 | Active surveillance for adverse events following immunization |
| Q30428338 | Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis |
| Q26750836 | Can Digital Tools Be Used for Improving Immunization Programs? |
| Q30368253 | Changes in immunization program managers' perceptions of programs' functional capabilities during and after vaccine shortages and pH1N1. |
| Q38207464 | Clinical focus: infections in pregnancy |
| Q47369849 | Development and application of two semi-automated tools for targeted medical product surveillance in a distributed data network |
| Q30354805 | Evaluating the safety of influenza vaccine using a claims-based health system. |
| Q34271547 | Guillain-Barre syndrome following quadrivalent human papillomavirus vaccination among vaccine-eligible individuals in the United States |
| Q30351998 | Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011. |
| Q30357675 | Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe |
| Q30374886 | Guillain-Barré syndrome and influenza vaccines: A meta-analysis. |
| Q92978114 | Guillain-Barré syndrome and influenza vaccines: current evidence |
| Q93193432 | Incidence of outcomes relevant to vaccine safety monitoring in a US commercially-insured population |
| Q30431960 | International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines |
| Q44475855 | Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity |
| Q33416609 | Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events |
| Q30836776 | Orphan therapies: making best use of postmarket data |
| Q30372280 | Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea. |
| Q30713580 | Post-licensure rapid immunization safety monitoring program (PRISM) data characterization |
| Q92158531 | Prevalence and types of vaccination errors from 2009 to 2018: A systematic review of the medical literature |
| Q31024252 | Prospective influenza vaccine safety surveillance using fresh data in the Sentinel System |
| Q30381595 | Refining the approach to vaccines against influenza A viruses with pandemic potential. |
| Q38940002 | Research Methods in Healthcare Epidemiology and Antimicrobial Stewardship: Use of Administrative and Surveillance Databases |
| Q30370076 | Responding to vaccine safety signals during pandemic influenza: a modeling study. |
| Q36902462 | Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination |
| Q30362413 | Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany |
| Q30428839 | Safety of pandemic (H1N1) 2009 monovalent vaccines in taiwan: a self-controlled case series study |
| Q92252833 | Surveillance for Guillain-Barré syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season |
| Q28602789 | The Pioneering Role of the Vaccine Safety Datalink Project (VSD) to Advance Collaborative Research and Distributed Data Networks |
| Q30365533 | The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. |
| Q36131193 | The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines |
| Q26773027 | The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper |
| Q28293098 | Update on Guillain-Barré syndrome |
| Q92241754 | Use of routinely collected electronic healthcare data for postlicensure vaccine safety signal detection: a systematic review |
| Q24197955 | Vaccines for preventing influenza in healthy adults |
| Q56603717 | Vaccines for preventing influenza in healthy adults |
Search more.